CLINICAL_TRIALS
trial_result
· 2012-09-10
Clinical Trial Update: A Long-Term Study of JNS007ER in Patients With Schizophrenia [Phase 3]
Summary
A Phase 3 long-term trial of JNS007ER in schizophrenia has been completed. Results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2012-09-10